ABVC BioPharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABVC BioPharma and other ETFs, options, and stocks.About ABVC
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002.
ABVC Key Statistics
Stock Snapshot
As of today, ABVC BioPharma(ABVC) shares are valued at $0.99. The company's market cap stands at 27.06M, with a P/E ratio of -2.59.
On 2026-08-03, ABVC BioPharma(ABVC) stock traded between a low of $0.99 and a high of $1.08. Shares are currently priced at $0.99, which is 0.0% above the low and -8.3% below the high.
The ABVC BioPharma(ABVC)'s current trading volume is 25.42K, compared to an average daily volume of 73.13K.
During the past year, ABVC BioPharma(ABVC) stock moved between $0.88 at its lowest and $3.40 at its peak.
During the past year, ABVC BioPharma(ABVC) stock moved between $0.88 at its lowest and $3.40 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.